Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Ondine Biomedical Inc

OBI.L ✗ NOT COMPLIANT ☆ Track — members

LSE · Healthcare · Medical Equipment, Supplies & Distribution ·

UK Micro Cap Analyst: N/A

Last Close

$0.19

▲ +0.00%

Market Cap $104.06M · Vol 4.49K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$104.06M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

45.45

Momentum

Beta

0.50

vs Market

52W High

$0.25

25.52% below

52W Low

$0.10

85.37% above

Volume

4.49K

Avg 375.20K

P/B

24.06

Price-to-book

ROE

N/A

Return on equity

Free Float

60.42%

Public shares

Shariah Compliance8 STANDARDS

✗ Ondine Biomedical Inc (OBI.L) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does OBI.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.85%

+0.00%

-8.33%

+48.65%

YTD

+57.14%

-5.17%

-9.88%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$1.93M
Net Income	$-21,507,578.00
Revenue Growth (YoY)	+37.23%
Gross Margin	41.19%
Operating Margin	-1,132.54%
Net Profit Margin	-1,115.53%
ROE	N/A
ROA · ROIC	-217.01% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	28.44
P/B	24.06
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	561.22M

Technical Indicators

50-Day SMA	$0.19
200-Day SMA	$0.16
RSI (14)	45.45
Beta	0.50
52-Week High	$0.25
52-Week Low	$0.10

Volume Today	4.49K
Avg Daily Volume (30D)	375.20K
Relative Volume	0.01x
Volatility (10D)	22.29
Volatility (30D)	30.74
Free Float	60.42%

Analyst Consensus

N/A

Current Price $0.19

Mean Target N/A

52W Low$0.10 52W High$0.25

Current

Target

$0.10 $0.25

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG013VGWYS2

ISINCA68234M2058

CountryCanada

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.02% MDT Medtronic PLC +0.76% COR Cencora Inc +1.23% 7741.T Hoya Corp +0.32% BDX Becton Dickinson and Co +0.79%

Company Profile

Ondine Biomedical Inc. is a Canadian life sciences company. The Company specializes in light-activated antimicrobial therapies (photo disinfection) for the prevention and treatment of infections, including those caused by multidrug-resistant organisms. The Company has a pipeline of investigational products, based on its proprietary photo disinfection technology, in various stages of development. The Company's nasal photo disinfection system has a CE mark in Europe and is approved in Canada, Australia, Mexico and several other countries under the name Steriwave. In the United States, it has been granted Qualified Infectious Disease Product designation and Fast Track status by the FDA and is undergoing clinical trials for regulatory approval. Its products beyond nasal photo disinfection include therapies for a variety of medical indications such as chronic sinusitis, ventilator-associated pneumonia, serious burns, chronic wounds, central line bloodstream infections and other indications.